Fake peptide alert after patient suffers torn oesophagus


A serious adverse event from an unapproved weight loss product prompted the medicines regulator to renew its warnings A new alert has been issued about counterfeit ‘retatrutide’ weight loss products, after a patient experienced “uncontrollable vomiting, resulting in a torn oesophagus” from an injectable found to contain eight times the level of semaglutide in locally

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘Continue to wear sunscreen’, TGA warns, amid ingredient probe
Next NSW Health 'committed' to expanding scope